MapLight Therapeutics, Inc. (MPLT)
30.27
+2.47
(+8.88%)
USD |
NASDAQ |
Jun 11, 16:00
30.27
0.00 (0.00%)
After-Hours: 18:28
MapLight Therapeutics Total Assets (Quarterly) : 418.79M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 418.79M |
| December 31, 2025 | 479.51M |
| September 30, 2025 | 257.22M |
| June 30, 2025 | 84.12M |
| Date | Value |
|---|---|
| March 31, 2025 | 111.57M |
| June 30, 2024 | |
| March 31, 2024 | 192.57M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Mineralys Therapeutics, Inc. | 652.86M |
| Evommune, Inc. | 322.46M |
| Arrowhead Pharmaceuticals, Inc. | 2.268B |
| Oncolytics Biotech, Inc. | 8.161M |
| Sangamo Therapeutics, Inc. | 59.96M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 18.95M |
| Shareholders Equity (Quarterly) | 399.83M |
| Debt to Equity Ratio | 0.014 |
| Current Ratio | 22.91 |
| Net Debt Paydown Yield | -0.12% |